Tumor burden score predicts tumor recurrence of non-functional pancreatic neuroendocrine tumors after curative resection
HPB Dec 13, 2019
Dong DH, Zhang XF, Lopez-Aguiar AG, et al. - Researchers conducted the study for analyzing the feasibility of Tumor Burden Score (TBS) to anticipate tumor recurrence following curative-intent resection of non-functional pancreatic neuroendocrine tumors (NF-pNETs). By a statistical tool, X-tile, the TBS cut-off values were determined. TBS's effect on recurrence-free survival (RFS) has been studied. Outcomes revealed that there was an incremental worsening of RFS among 842 patients with NF-pNETs as the TBS increased. Findings suggested a strong association of TBS with the risk of recurrence and outperformed both tumor size and number alone.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries